N (%) | |
---|---|
Mean age (years) | 51.11 + 11.80 |
Mean BMI (Kg/m2) | 23.77 + 3.77 |
Mean operative time (minutes) | 159.13 + 68.29 |
Mean hospital length (days) | 7.7 + 3.2 |
Single | 24 (21.4) |
Married | 87 (77.7) |
Divorce | 1 (0.9) |
Nulliparity | 34 (30.4) |
Underlying disease * | 46 (41.1) |
Hormone usage | 16 (14.3) |
Current OCP usage | 5 |
Previous OCP usage | 8 |
Previous hormonal therapy usage | 3 |
Chemotherapy | 15 (12.8) |
Neoadjuvant setting | 7 |
Previous chemotherapy | 8 |
Previous radiation | 4 (3.6) |
Diagnosis | |
Benign | 68 (60.71) |
Myoma | 37 |
Adenomyosis | 11 |
endometriosis | 8 |
Ovarian tumor | 7 |
Other | 5 |
Malignancy | 44 (39.28) |
CA ovary | 6 |
CA cervix | 12 |
CA endometrium | 12 |
CA vulva | 1 |
CA fallopian tube | 7 |
Uterine sarcoma | 2 |
Ovarian metastasis | 4 |
Operation | |
TAH | 1 (0.9) |
TAH and adnexal surgery | 50 (44.6) |
TAH and adnexal surgery and other | 16 (14.3) |
TAH and bowel surgery | 3 (2.7) |
Adnexal surgery | 5 (4.5) |
Surgical staging | 23 (20.5) |
RHPL | 10 (8.9) |
Myomectomy | 2 (1.8) |
Vulva surgery | 2 (1.8) |
Perioperative blood transfusion | 22 (19.6) |
1 unit | 6 (5.4) |
2 unit | 11 (9.8) |
3 unit | 1 (0.9) |
4–8 unit | 4 (3.6) |